get a key
steadybase-$ company SLDB
account_id none on file
legal_name Solid Biosciences Inc.
ticker SLDB
cik 1707502
domain solidbio.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 10 executives 3 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include legal fees relating to patent and corporate matters, professional fees for accounting, auditing, tax and consulting services, insurance costs, travel expenses, and facility-related expenses.

filing / Aug 6, 2026 / receipt

• costs of outside consultants engaged to assist in our research and development activities, including their fees, equity-based compensation and related travel expenses;

filing / Aug 6, 2026 / receipt

In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs.

filing / Aug 6, 2026 / receipt

If we expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and Candidates outside of the United States, which could limit our growth potential and increase our development costs.

filing / Aug 6, 2026 / receipt

The continuing efforts of the government, insurance companies, managed care organizations and other health care payors to contain or reduce costs of health care may adversely affect:

filing / Aug 6, 2026 / receipt

General and administrative expenses also include legal fees relating to patent and corporate matters, professional fees for accounting, auditing, tax and consulting services, insurance costs, travel expenses, and facility-related expenses.

filing / May 12, 2026 / receipt

• costs of outside consultants engaged to assist in our research and development activities, including their fees, equity-based compensation and related travel expenses;

filing / May 12, 2026 / receipt

In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs.

filing / May 12, 2026 / receipt

If we expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and Candidates outside of the United States, which could limit our growth potential and increase our development costs.

filing / May 12, 2026 / receipt

The continuing efforts of the government, insurance companies, managed care organizations and other health care payors to contain or reduce costs of health care may adversely affect:

filing / May 12, 2026 / receipt

executives
Alexander (Bo) Cumbo President and Chief Executive Officer - receipt
Ian Smith Chairman of the Board - receipt
Kevin Tan Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-02 earnings call scheduled ir
changes
2023-01-09 Chief Financial Officer, appointed sec_8k
2022-12-05 Chief Executive Officer, departed sec_8k
2022-12-05 President and Chief Executive Officer, appointed sec_8k
2022-09-30 Chief Executive Officer, departed sec_8k
2020-06-18 Chairman of the Board, appointed sec_8k
mcp_package_hint
steadybase-$